A systematic review on machine learning approaches in the diagnosis and prognosis of rare genetic diseases

• Published in: Journal of biomedical informatics 2023-07, Vol.143, p.104429-104429, Article 104429
• Main Authors: Roman-Naranjo, P., Parra-Perez, A.M., Lopez-Escamez, J.A.
• Format: Article
• Language: English
• Subjects: Algorithms; Artificial intelligence; DNA-sequencing; Genomics; Genomics - methods; Humans; Machine Learning; Precision medicine; Prognosis; Rare diseases; Rare Diseases - diagnosis; Rare Diseases - genetics; Rare variants
• ISSN: 1532-0464; 1532-0480
• DOI: 10.1016/j.jbi.2023.104429

[Display omitted] •ML can enhance diagnostic accuracy in rare genetic diseases.•We identified key features for ML models in sequencing data.•This systematic review may support ML model development in rare disease diagnosis. The diagnosis of rare genetic diseases is often challenging due to the complexity of the genetic underpinnings of these conditions and the limited availability of diagnostic tools. Machine learning (ML) algorithms have the potential to improve the accuracy and speed of diagnosis by analyzing large amounts of genomic data and identifying complex multiallelic patterns that may be associated with specific diseases. In this systematic review, we aimed to identify the methodological trends and the ML application areas in rare genetic diseases. We performed a systematic review of the literature following the PRISMA guidelines to search studies that used ML approaches to enhance the diagnosis of rare genetic diseases. Studies that used DNA-based sequencing data and a variety of ML algorithms were included, summarized, and analyzed using bibliometric methods, visualization tools, and a feature co-occurrence analysis. Our search identified 22 studies that met the inclusion criteria. We found that exome sequencing was the most frequently used sequencing technology (59%), and rare neoplastic diseases were the most prevalent disease scenario (59%). In rare neoplasms, the most frequent applications of ML models were the differential diagnosis or stratification of patients (38.5%) and the identification of somatic mutations (30.8%). In other rare diseases, the most frequent goals were the prioritization of rare variants or genes (55.5%) and the identification of biallelic or digenic inheritance (33.3%). The most employed method was the random forest algorithm (54.5%). In addition, the features of the datasets needed for training these algorithms were distinctive depending on the goal pursued, including the mutational load in each gene for the differential diagnosis of patients, or the combination of genotype features and sequence-derived features (such as GC-content) for the identification of somatic mutations. ML algorithms based on sequencing data are mainly used for the diagnosis of rare neoplastic diseases, with random forest being the most common approach. We identified key features in the datasets used for training these ML models according to the objective pursued. These features can support the development of future ML models in the diagnosis